Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy

Importance Optical coherence tomographic angiography (OCT-A) is able to visualize retinal microvasculature without the need for injection of fluorescein contrast dye. Nevertheless, it is only able to capture a limited view of macula and does not show leakage. Objectives To evaluate the retinal microvasculature using OCT-A in patients with type 2 diabetes as well as the association of OCT-A characteristics with diabetic retinopathy (DR) and systemic risk factors. Design, Setting, and Participants A prospective, observational study was conducted from January 1 to June 30, 2016, at medical retina clinics at the Singapore National Eye Center among 50 patients with type 2 diabetes with and without DR (n = 100 eyes). We examined the retinal microvasculature with swept-source OCT-A and a semiautomated software to measure the capillary density index (CDI) and fractal dimension (FD) at the superficial vascular plexus (SVP) and deep retinal vascular plexus (DVP). We collected data on histories of patients’ glycated hemoglobin A1c, hypertension, hyperlipidemia, smoking, and renal impairment. Main Outcomes and Measures The CDI and FD at the SVP and DVP for each severity level of DR and the association of systemic risk factors vs the CDI and FD. Results The mean (SD) glycated hemoglobin A1c of the 50 patients (26 men and 24 women; 35 Chinese; mean [SD] age, 59.5 [8.9] years) was 7.9% (1.7%). The mean (SD) CDI at the SVP decreased from 0.358 (0.017) in patients with no DR to 0.338 (0.012) in patients with proliferative DR (P < .001) and at the DVP decreased in patients with no DR from 0.361 (0.019) to 0.345 (0.020) in patients with proliferative DR (P = .04). The mean (SD) FD at the SVP increased from 1.53 (0.05) in patients with no DR to 1.60 (0.05) in patients with proliferative DR (P < .01) and at the DVP increased from 1.55 (0.06) in patients with no DR to 1.61 (0.05) in patients with proliferative DR (P = .02). For systemic risk factors, hyperlipidemia (odds ratio [OR], 9.82; 95% CI, 6.92-11.23; P < .001), smoking (OR, 10.90; 95% CI, 8.23-12.34; P < .001), and renal impairment (OR, 3.72; 95% CI, 1.80-4.81; P = .05) were associated with reduced CDI, while increased glycated hemoglobin A1c (≥8%) (OR, 8.77; 95% CI, 5.23-10.81; P < .01) and renal impairment (OR, 10.30; 95% CI, 8.21-11.91; P < .001) were associated with increased FD. Conclusions and Relevance Optical coherence tomographic angiography is a novel imaging modality to quantify the retinal capillary microvasculature in patients with diabetes. It can be potentially used in interventional trials to study the effect of systemic risk factors on the microvasculature that was previously not accessible in a noninvasive manner. The relevance of these findings relative to visual acuity, however, remains largely unknown at this time.

[1]  Carmen A. Puliafito,et al.  Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography , 2016, Investigative ophthalmology & visual science.

[2]  P. Mitchell,et al.  Retinal Vascular Geometry in Asian Persons with Diabetes and Retinopathy , 2012, Journal of diabetes science and technology.

[3]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Dawn A Sim,et al.  The Evaluation of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography. , 2016, Investigative ophthalmology & visual science.

[5]  A. Yoshida,et al.  Effects of Habitual Cigarette Smoking on Retinal Circulation in Patients With Type 2 Diabetes. , 2016, Investigative ophthalmology & visual science.

[6]  J. J. Wang,et al.  Dyslipidaemia and microvascular disease in the retina , 2005, Eye.

[7]  Martin F. Kraus,et al.  Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. , 2014, Ophthalmology.

[8]  H. Novotny,et al.  A Method of Photographing Fluorescence in Circulating Blood in the Human Retina , 1961, Circulation.

[9]  Ruikang K. Wang,et al.  Quantifying Optical Microangiography Images Obtained from a Spectral Domain Optical Coherence Tomography System , 2012, Int. J. Biomed. Imaging.

[10]  R. Spaide,et al.  Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. , 2015, JAMA ophthalmology.

[11]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[12]  T. Deckert,et al.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion , 1988, Diabetologia.

[13]  H A Lehr,et al.  Microcirculatory Dysfunction Induced by Cigarette Smoking , 2000, Microcirculation.

[14]  P. Keane,et al.  Optical coherence tomography angiography: a non-invasive tool to image end-arterial system , 2016, Expert review of medical devices.

[15]  Wynne Hsu,et al.  Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes , 2010, Diabetes Care.

[16]  R P Murphy,et al.  Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. , 1991, Ophthalmology.

[17]  Christiane,et al.  WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects , 2001, Journal of postgraduate medicine.

[18]  J. Fujimoto,et al.  IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY , 2015, Retina.

[19]  Richard F Spaide,et al.  Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. , 2015, JAMA ophthalmology.

[20]  T. Wong,et al.  Fractal analysis of the retinal vasculature and chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  T. Wong,et al.  Structural changes in the retinal microvasculature and renal function. , 2013, Investigative ophthalmology & visual science.

[22]  Carmen A Puliafito,et al.  OCT angiography in healthy human subjects. , 2014, Ophthalmic surgery, lasers & imaging retina.

[23]  Z. Varghese,et al.  LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE , 1982, The Lancet.

[24]  T. Wong,et al.  Quantitative Assessment of Early Diabetic Retinopathy Using Fractal Analysis , 2009, Diabetes Care.

[25]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[26]  Mayss Al-Sheikh,et al.  Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy. , 2016, Investigative ophthalmology & visual science.

[27]  J D Gass,et al.  A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. IV. Diabetic retinal angiopathy. , 1968, Archives of ophthalmology.

[28]  A. Daxer,et al.  Mechanisms in retinal vasculogenesis: an analysis of the spatial branching site correlation. , 1995, Current eye research.

[29]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[30]  J. Isner,et al.  Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. , 1997, Circulation.

[31]  David Huang,et al.  Automated Quantification of Capillary Nonperfusion Using Optical Coherence Tomography Angiography in Diabetic Retinopathy. , 2016, JAMA ophthalmology.

[32]  C. Tsalamandris,et al.  Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetic patients , 1993, Diabetologia.

[33]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Dawn A Sim,et al.  Predictive factors for the progression of diabetic macular ischemia. , 2013, American journal of ophthalmology.

[35]  L. Jampol,et al.  Retinal arteriolar changes in patients with hyperlipidemias. , 1988, Retina.

[36]  Tien Yin Wong,et al.  Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. , 2010, Ophthalmology.